FDA warning letters dive into detail in the January 2018 AHPA Report!

AHPA Reports

AHPA's monthly newsletter. Members log in to access issues of the AHPA Report.

FDA warning letters dive into detail in the January 2018 AHPA Report!

January 2018 AHPA Report

Published: Thursday, January 11, 2018

In this issue of AHPA Report:

Special topic:

FDA warning letters dive into detail by Anthony Young, Esq., Kleinfeld, Kaplan & Becker LLP and AHPA General Counsel

Plus:

  • AHPA submits comments on pre-DSHEA dietary ingredients list

  • AHPA participates in CIR panel discussion on 4 herbal ingredients

  • Industry coalition: Dietary supplements cannot claim to treat opioid addiction

  • AHPA mourns the passing of Jim Duke
    ...and much more!

Print

2018 Annual Fund Sponsors

   

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.